Assessing PAH disease remission in a clinical trial

Presented at PVRI 2026 Congress by Jim White, University of Rochester

Summary

Drug therapy focuses on improving patient outcomes through personalised treatment. Measuring improvement in clinical trials is crucial, as is incorporating patient voices in treatment decisions. The conversation highlights the need for better metrics to evaluate progress and the challenges of including diverse populations in trials. Innovative methodologies are essential for capturing meaningful data and ultimately enhancing patient outcomes.

Generated with AI, edited by PVRI